Factors Affecting the Initial Eradication Rate of Helicobacter pylori Infection
10.3969/j.issn.1008-7125.2021.03.004
- Author:
Zhe ZHAO
1
;
Jingtao ZHAO
1
;
Hao MEI
1
;
Jie HU
1
;
Nayun SU
1
;
Yangjie ZHU
1
;
Yi ZHANG
1
;
Jing YANG
1
;
Chunhui LAN
1
Author Information
1. Department of Gastroenterology, Daping Hospital, Army Medical University
- Publication Type:Journal Article
- Keywords:
Compliance;
CYP2C19 Gene Polymorphism;
Helicobacter pylori;
Risk Factors;
Smoking;
Therapy
- From:
Chinese Journal of Gastroenterology
2021;26(3):145-150
- CountryChina
- Language:Chinese
-
Abstract:
Background: Helicobacter pylori (Hp) infection is related to the occurrence of many upper digestive tract diseases, and the eradication rate has been decreasing year by year. Aims: To investigate the risk factors affecting initial eradication rate of Hp infection. Methods: Clinical data of 428 patients with Hp infection were retrospectively analyzed. Four regimens (14-day esomeprazole 20 mg + amoxicillin 750 mg, qid; 10-day esomeprazole 20 mg + amoxicillin 750 mg, qid; 14-day esomeprazole 20 mg + amoxicillin 1 000 mg, tid; 14-day esomeprazole 20 mg + bismuth 220 mg + amoxicillin 1 000 mg + clarithromycin 500 mg, bid) were given, and effect of antibiotic resistance on Hp eradication was analyzed, the relevant risk factors affecting the eradication rate of Hp were investigated. Results: The eradication rate of ITT analysis was 86.4%, PP analysis was 87.6%. The eradication rates of 4 regimens for ITT analysis were 90.8%, 79.8%, 82.7%, 91.9%, respectively, and were 90.8%, 81.2%, 85.1%, 92.7% for PP analysis, respectively. The antibiotic resistance rate was 30.3%, 97.4% and 36.8% for clarithromycin, metronidazole and levofloxacin, respectively. The recurrence rate of 116 patients was 4.3% after one year of eradication. Smoking, poor compliance, CYP2C19 gene polymorphism were risk factors for eradication rate of Hp (P<0.05). Conclusions: Smoking, poor compliance and ultra-rapid metabolizers, extensive metabolizers of CYP2C19 gene polymorphism can reduce Hp eradication rate. In clinical practice, patient education should be strengthened to urge patients to quit smoking. The quality of follow-up should be improved and proton pump inhibitor that has less impact on CYP2C19 gene polymorphism should be used, thereby increase the Hp eradication rate.
